The authors reply

American Journal of Epidemiology

Volumn 177, Issue 8, 2013, Pages 865-866

  Khalili, Davood ^a,b   Hadaegh, Farzad ^a   Steyerberg, Ewout W ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FALSE POSITIVE RESULT; HEALTH ECONOMICS; HUMAN; INCIDENCE; LETTER; MEDICAL DECISION MAKING; NET BENEFIT FRACTION; RISK; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS;

CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE;

EID: 84876218953     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwt039     Document Type: Letter

References (7)

1. Janes H, Pepe M. Re:"Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance:the Tehran Lipid and Glucose Study" [letter]. Am JEpidemiol. 2013;177(8):864-865.
2. Baker SG, Cook NR, Vickers A, et al. Using relative utility curves to evaluate risk prediction. J R Stat Soc Ser A Stat Soc. 2009;172(4):729-748.
3. Vickers AJ, Elkin EB. Decision curve analysis:a novel method for evaluating prediction models. Med Decis Making. 2006; 26(6):565-574.
4. Van Calster B, Vickers AJ, Pencina MJ, et al. Evaluation of markers and risk prediction models:overview of relationships between NRI and decision-analytic measures [published online ahead ofprint January 11, 2013]. Med Decis Making. (doi:10.1177/0272989X12470757).
5. Khalili D, Hadaegh F, Soori H, et al. Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance:the Tehran Lipid and Glucose Study. Am JEpidemiol. 2012;176(3):177-186.
6. Torgerson DJ, Raftery J. Economic notes:discounting. BMJ. 1999;319(7214):914-915.
7. Hadaegh F, Zabetian A, Sarbakhsh P, et al. Appropriate cutoff values of anthropometric variables to predict cardiovascular outcomes:7.6 years follow-up in an Iranian population. Int J Obes (Lond). 2009;33(12):1437-1445.